RIS ID
73747
Abstract
Background/Aims: Chronic kidney disease (CKD) is a major health issue worldwide. The aim of this study was to explore factors associated with CKD progression in Australian nephrology practices. Methods: This was a retrospective study utilising an electronic medical record (EMR), Audit4 (Software for Specialists, Australia). The baseline visit was defined as the first entry into the EMR. The primary outcome was the rate of change in estimated glomerular filtration rate (eGFR). Results: 1,328 patients were included with a mean eGFR at baseline of 37.4 ± 0.7 ml/min/1.73 m2, a mean follow-up of 17.7 months and a mean annual rate of change in eGFR of –0.84 ± 0.26 ml/min/1.73 m2. Univariate analysis demonstrated that women, smokers, and patients prescribed erythropoiesis-stimulating agents (ESA) had a significantly more rapid decline in eGFR (p = 0.007, 0.033, and 0.003, respectively). On multivariate analysis: gender, age, prescription of ESA and phosphate binders, and baseline eGFR were significantly associated with CKD progression (p = 0.003, 0.004,
Publication Details
Boudville, N., Kemp, A., Moody, H., Fassett, R. G., Pedagogos, E., Nelson, C., Healy, H., Mangos, G., Kirkland, G., Kay, T., De Crespigny, P., Hoffman, D. & Waugh, D. (2012). Factors associated with chronic kidney disease progression in Australian nephrology practices. Nephron Clinical Practice, 121 (1-2), C36-C41.